Mr. Paul Walker

Mr. Walker is a General Partner at New Enterprise Associates (NEA), an investment firm focused on venture capital and growth equity investments, where he has specialized in later-stage biotechnology and life sciences investments since 2008.  Mr. Walker is a member of the Boards of Directors of Allakos, Inc. and Tracon Pharmaceuticals and was previously a member of the Board of Directors of TESARO.  He is also a board observer at Sunesis Pharmaceuticals, Inc., and manages a number of NEA’s other late-stage and public investments.  Prior to NEA, Mr. Walker worked at MPM Capital and was a General Partner with the MPM BioEquities Fund, where he specialized in public, PIPE and mezzanine-stage life sciences investing. Previously, he was a portfolio manager at Franklin Templeton Investments. Mr. Walker received a Bachelor of Science in Biochemistry and Cell Biology from the University of California at San Diego, and holds the Chartered Financial Analyst designation.